Portfolio
Life Sciences
-
AneuRx Stent grafts for abdominal aortic aneurysm
Acquired by Medtronic
(MDT) -
Arbor Health Care Skilled nursing and subacute care centers
Acquired by Extendicare
(EXE) -
-
Athena Neurosciences Pharmaceuticals for neurological diseases
Acquired by Elan Corp., plc
(ELN) -
Avidia New protein structural motifs for treating human disease.
Acquired by Amgen
(AMGN) -
-
Cabochon Aesthetics A medical device company developing effective scientific solutions for aesthetic procedures.
www.cabochoninc.com
PRIVATE -
Calithera Biosciences A new class of anti-cancer therapeutics based on activation of caspases
www.calithera.com
-
-
CardioThoracic Systems Devices for minimally-invasive heart surgery
www.cardioth.com
Acquired by Guidant
(GDT) -
Cardiomind, Inc. Stents for small diameter and distal hard-to-reach coronary vessels.
www.cardiomind.com
PRIVATE -
-
Catalyst Biosciences Developer of engineered proteases as protein therapeutics that attack targets which cause disease.
www.catbio.com
PRIVATE -
-
Elcelyx Therapeutics Elcelyx is a biotechnology company that is creating new therapeutics for the treatment of diabetes and obesity
-
Embol-X Devices to protect the brain from stroke
Acquired by Edwards Lifesciences
(EW) -
FoldRx Pharmaceuticals Treatments for diseases caused by misfolding of specific proteins
www.foldrx.com
-
ForSight Labs is an ophthalmic incubator creating unique solutions that address unmet clinical needs in diseases of the eye.
www.forsightlabs.com
PRIVATE -
Galleon Pharmaceuticals Innovative medicines for pulmonology, neurology, cardiology, sleep medicine and pediatrics
www.galleonpharma.com
PRIVATE -
Gliatech Devices for the treatment of the nervous system
(GLIA) -
GlobeImmune Therapeutic vaccine platform technology targeting infectious disease and cancer
www.globeimmune.com
PRIVATE -
IPC - The Hospitalist Company Hospital-based physician practice management company
www.ipcm.com
PRIVATE -
Intact Medical Develops minimally invasive RF-based surgical instruments for biopsy
www.neothermia.com
PRIVATE -
LuMend Devices for treating chronic total occlusions
PRIVATE -
Medaphis Business management services for hospitals/physicians
Acquired by Per-Sé
(PSTI) -
Miramar Device for the treatment of hyperhidrosis and aesthetic complications of excessive sweating
www.miramarlabs.com
PRIVATE -
Morphotek, Inc. Next generation antibodies production technology.
www.morphotek.com
Acquired by EISIA -
-
-
OncoMed Pharmaceuticals Inc. Biological therapeutics targeting cancer stem cells
www.oncomed.com
PRIVATE -
Optiscan Biomedical Corporation Instruments and sensors for accurate, automated measurement of blood glucose levels
www.optiscancorp.com
PRIVATE -
-
Perclose Suture-mediated vascular closure systems
Acquired by Abbott Labs
(ABT) -
-
Ra Pharmaceuticals Platform for orally available and cell permeable biologics
-
Relievant Medsystems Relievant Medsystems is developing a treatment for lower back pain
www.Relievant.com
PRIVATE -
Replidyne Drug discovery and development focused on a new class of antibiotics
www.replidyne.com
(RDYN) -
Ribozyme Pharmaceuticals RNA-based pharmaceuticals for human disease
(RZYM) -
-
Satiety, Inc. Technology for endoscopists and gastrointestinal surgeons for the treatment of obesity
www.satietyinc.com
PRIVATE -
Sequana Therapeutics Gene discovery via functional genomics
Acquired by Axys Pharmaceutical
(AXPH) -
SetPoint Medical Neuro-modulation platform for the treatment of a variety of acute and chronic diseases
www.setpointmedical.com
PRIVATE -
-
-
-
-
Third Millenium Healthcare Systems Internet-based workflow solutions for healthcare organizations
Merged with CareMedic -
Threshold Pharmaceutical, Inc. Developing targeted therapies for treatment of cancer.
www.thresholdpharm.com
(THLD) -
Tragara Pharmaceuticals Developer of drugs for the treatment of cancer and inflammation-related diseases.
www.tragarapharma.com
PRIVATE -
-
Trellis Bioscience Platform technology for monoclonal antibody development and production
www.trellisbio.com
PRIVATE -
-
-
XTENT Next-generation products designed to increase the market penetration of stents
www.xtentinc.com
(XTNT)